First, western blotting was used to analyze the protein expression of VEGFR2 on HUVECs treated with CM from SPRY4‐IT1‐silenced and SPRY4‐IT1‐overexpressed glioma cells. The gene discussed is SPRY4; the disease is central nervous system cancer.